Poli Daniela, Antonucci Emilia, Ageno Walter, Prandoni Paolo, Barillari Giovanni, Bitti Giuseppina, Imbalzano Egidio, Bucherini Eugenio, Chistolini Antonio, Fregoni Vittorio, Galliazzo Silvia, Gandolfo Alberto, Grifoni Elisa, Mastroianni Franco, Panarello Serena, Pesavento Raffaele, Pedrini Simona, Sala Girolamo, Pignatelli Pasquale, Preti Paola, Simonetti Federico, Sivera Piera, Visonà Adriana, Villalta Sabina, Marcucci Rossella, Palareti Gualtiero
SOD Malattie Aterotrombotiche, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
Fondazione Arianna Anticoagulazione, Bologna, Italy.
TH Open. 2022 Sep 12;6(3):e251-e256. doi: 10.1055/a-1878-6806. eCollection 2022 Jul.
Coronavirus disease 2019 (COVID-19) infection causes acute respiratory insufficiency with severe interstitial pneumonia and extrapulmonary complications; in particular, it may predispose to thromboembolic disease. The reported incidence of thromboembolic complications varies from 5 to 30% of cases. We conducted a multicenter, Italian, retrospective, observational study on COVID-19 patients admitted to ordinary wards, to describe the clinical characteristics of patients at admission and bleeding and thrombotic events occurring during the hospital stay. The number of hospitalized patients included in the START-COVID-19 Register was 1,135, and the number of hospitalized patients in ordinary wards included in the study was 1,091, with 653 (59.9%) being males and 71 years (interquartile range 59-82 years) being the median age. During the observation, two (0.2%) patients had acute coronary syndrome episodes and one patient (0.1%) had an ischemic stroke; no other arterial thrombotic events were recorded. Fifty-nine patients had symptomatic venous thromboembolism (VTE) (5.4%) events, 18 (30.5%) deep vein thrombosis (DVT), 39 (66.1%) pulmonary embolism (PE), and 2 (3.4%) DVT+PE. Among patients with DVT, eight (44.4%) were isolated distal DVT and two cases were jugular thrombosis. Among patients with PE, seven (17.9%) events were limited to subsegmental arteries. No fatal PE was recorded. Major bleeding events occurred in nine (1.2%) patients and clinically relevant nonmajor bleeding events in nine (1.2%) patients. All bleeding events occurred among patients receiving thromboprophylaxis, more frequently when treated with subtherapeutic or therapeutic dosages. Our findings confirm that patients admitted to ordinary wards for COVID-19 infection are at high risk for thromboembolic events. VTE recorded among these patients is mainly isolated PE, suggesting a peculiar characteristic of VTE in these patients.
2019冠状病毒病(COVID-19)感染可导致急性呼吸功能不全,并伴有严重的间质性肺炎和肺外并发症;特别是,它可能易引发血栓栓塞性疾病。报告的血栓栓塞并发症发生率在病例的5%至30%之间。
我们对入住普通病房的COVID-19患者进行了一项多中心、意大利的回顾性观察研究,以描述入院时患者的临床特征以及住院期间发生的出血和血栓形成事件。
START-COVID-19登记册中纳入的住院患者数量为1135例,本研究纳入的入住普通病房的住院患者数量为1091例,其中男性653例(59.9%),中位年龄为71岁(四分位间距59 - 82岁)。在观察期间,2例(0.2%)患者发生急性冠状动脉综合征发作,1例患者(0.1%)发生缺血性中风;未记录到其他动脉血栓形成事件。59例患者发生有症状的静脉血栓栓塞(VTE)(5.4%)事件,18例(30.5%)为深静脉血栓形成(DVT),39例(66.1%)为肺栓塞(PE),2例(3.4%)为DVT + PE。在DVT患者中,8例(44.4%)为孤立性远端DVT,2例为颈静脉血栓形成。在PE患者中,7例(17.9%)事件局限于亚段动脉。未记录到致命性PE。9例(1.2%)患者发生大出血事件,9例(1.2%)患者发生临床相关的非大出血事件。所有出血事件均发生在接受血栓预防治疗的患者中,在接受亚治疗剂量或治疗剂量治疗时更常见。
我们的研究结果证实,因COVID-19感染入住普通病房的患者发生血栓栓塞事件的风险很高。这些患者中记录到的VTE主要是孤立性PE,表明这些患者的VTE具有特殊特征。